Sandrine Pereira, PhD
After having defended my doctoral thesis in medical genetics and biology (France) in 2005, I carried out several postdoctoral fellowships which enabled me to specialize in different fields such as genetics, neurobiology but also in radiobiology with Dr Nicolas Foray. Today as a radiobiologist, my main projects consist of the prediction of radiation-induced toxicity in different cancers in adults and children.
Main Articles:
- Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, Cadiñanos J, Osorio FG, Foray N, Cobo J, de Carlos F, Lévy N, Freije JM, López-Otín C. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med. 2008 Jul;14(7):767-72.
- Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo ML, Devic C et al. Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and Performance. IJROBP 2018; 100, 353-360.
- Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, Foray N. The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions. IJROBP 2018;101(3):690-693
- Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin, G, Foray N and Pereira S. Proof of Concept of a Binary Blood Assay for Predicting Cancers 2021; 13, 2477.
Grants:
Grant for the international congress of epilepsy, Lisbon 2003
Grant « 1er Prix Jean Frézal », Assises de Génétique, Lille, France 2008
Grant « 1er Prix APRAT, CIRFA », Annecy, France 2009
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none